IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+14.89%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$283M
AUM Growth
+$42.6M
Cap. Flow
+$49.2M
Cap. Flow %
17.35%
Top 10 Hldgs %
54.99%
Holding
128
New
25
Increased
11
Reduced
19
Closed
34

Top Buys

1
SLRN
ACELYRIN
SLRN
$61M
2
IDYA icon
IDEAYA Biosciences
IDYA
$11.5M
3
NUVL icon
Nuvalent
NUVL
$11.5M
4
IRON icon
Disc Medicine
IRON
$10.7M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
$8.56M

Top Sells

1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$13.5M
2
IMVT icon
Immunovant
IMVT
$12M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7.66M
4
BLU
BELLUS Health Inc.
BLU
$6.37M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$5.19M

Sector Composition

1 Healthcare 97.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TERN icon
26
Terns Pharmaceuticals
TERN
$651M
$2.76M 0.44%
315,480
-405,861
-56% -$3.55M
BDTX icon
27
Black Diamond Therapeutics
BDTX
$164M
$2.75M 0.44%
+545,103
New +$2.75M
DCPH
28
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.46M 0.39%
174,510
– –
ESPR icon
29
Esperion Therapeutics
ESPR
$490M
$2.37M 0.38%
1,705,605
+350,000
+26% +$487K
ROIV icon
30
Roivant Sciences
ROIV
$8.6B
$2.27M 0.36%
225,000
-350,000
-61% -$3.53M
ACRS icon
31
Aclaris Therapeutics
ACRS
$223M
$2.08M 0.33%
200,163
-100,000
-33% -$1.04M
KZR icon
32
Kezar Life Sciences
KZR
$28.5M
$2.06M 0.33%
84,160
– –
BIVI icon
33
BioVie
BIVI
$12.6M
$1.93M 0.31%
4,486
+1,000
+29% +$431K
ICPT
34
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.77M 0.28%
160,200
+75,000
+88% +$830K
ELEV
35
DELISTED
Elevation Oncology
ELEV
$1.75M 0.28%
+1,149,490
New +$1.75M
LEGN icon
36
Legend Biotech
LEGN
$6.64B
$1.73M 0.27%
+25,000
New +$1.73M
MRUS icon
37
Merus
MRUS
$5.04B
$1.66M 0.26%
63,125
-145,525
-70% -$3.83M
IMUX icon
38
Immunic
IMUX
$79.4M
$1.63M 0.26%
650,000
– –
JSPR icon
39
Jasper Therapeutics
JSPR
$44.2M
$1.54M 0.25%
112,509
-120
-0.1% -$1.64K
SCPH icon
40
scPharmaceuticals
SCPH
$296M
$1.53M 0.24%
+150,000
New +$1.53M
CRBP icon
41
Corbus Pharmaceuticals
CRBP
$119M
$1.51M 0.24%
192,260
– –
BLUE
42
DELISTED
bluebird bio
BLUE
$1.36M 0.22%
20,631
– –
MIST icon
43
Milestone Pharmaceuticals
MIST
$151M
$1.31M 0.21%
460,416
– –
KALV icon
44
KalVista Pharmaceuticals
KALV
$713M
$1.26M 0.2%
140,000
– –
OKUR
45
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$1.02M 0.16%
15,582
– –
PTGX icon
46
Protagonist Therapeutics
PTGX
$3.62B
$967K 0.15%
+35,000
New +$967K
ARDX icon
47
Ardelyx
ARDX
$1.57B
$945K 0.15%
278,825
-300,000
-52% -$1.02M
TYRA icon
48
Tyra Biosciences
TYRA
$657M
$820K 0.13%
48,170
– –
TCON
49
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$805K 0.13%
138,277
– –
PRQR icon
50
ProQR Therapeutics
PRQR
$256M
$766K 0.12%
472,625
– –
1
2
3 4 5